Related Experiment Video
Updated: Mar 8, 2026

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
Published on: October 13, 2022
Role Of S-Nitrosylation In The Extrinsic Apoptotic Signalling Pathway In Cancer
1Laboratoire d'Immunologie et Immunothérapie des Cancers, EPHE-Université de Bourgogne EA 7269, Faculté de Médecine, Dijon, France.
Abstract:
One of the key features of tumour cells is the acquisition of resistance to apoptosis. Thus, determining therapeutic strategies that circumvent apoptotic resistance and result in tumor regression is a challenge. One strategy to induce apoptosis is to activate death receptor signalling pathways. Members of the Tumor Necrosis Factor TNF-family death receptors ligand (TRAIL, FasL and TNF-α) can originate from immune and non-immune cells. Death receptors, engaged by cognate ligands, can initiate multiple signaling pathways, which can generate diverse outcomes, including non-apoptosis-related signal. Knowledge on the molecular mechanisms (that determine death or survival of tumour cells) following exposure to the TNF-family death receptors ligands have demonstrated that post-translational modifications of the signaling pathway components play a critical role in determining cell fate. Cell death can be sensed by nitric oxide (NO) in a wide variety of tumour cells. S-nitrosylation, the covalent modification of a protein cysteine thiol by an NO moiety, has emerged as an important post-translational regulation for the TNF-family death receptor signaling pathways. It has been demonstrated that death receptor DR4 (TRAIL-R1) becomes S-nitrosylated and promotes apoptosis following a specific NO donor treatment (Tang et al., 2006). Then, our group has shown that S-nitrosylation of Fas, following glyceryl trinitrate (GTN) exposure, promotes redistribution of the receptor to lipid rafts, formation of the death-inducing signal complex (DISC), and induction of cell death. Finally, I will discuss our recent efforts to decipher regulatory mechanism of the TNF-α/TNFR1 signalling cell death pathway by S-nitrosylation following GTN treatment.
Insights
Tumor cells resist apoptosis, hindering cancer treatment. Nitric oxide (NO) modification, specifically S-nitrosylation, of death receptors like Fas can trigger apoptosis, offering a potential therapeutic strategy for tumor regression.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Tumor cells often develop resistance to apoptosis, a programmed cell death mechanism, posing a significant challenge for cancer therapy.
- Activating death receptor signaling pathways is a key strategy to overcome apoptotic resistance and induce tumor regression.
- Tumor Necrosis Factor (TNF)-family death receptor ligands, such as TRAIL, FasL, and TNF-α, play crucial roles in initiating cell death signaling.
Purpose of the Study:
- To investigate the role of post-translational modifications, particularly S-nitrosylation, in regulating TNF-family death receptor signaling pathways.
- To explore how nitric oxide (NO) influences cell fate decisions in tumor cells exposed to death receptor ligands.
- To elucidate the molecular mechanisms by which S-nitrosylation of death receptors promotes apoptosis and tumor regression.
Main Methods:
- Examining the S-nitrosylation of death receptors (DR4 and Fas) following treatment with NO donors or glyceryl trinitrate (GTN).
- Analyzing the effect of S-nitrosylation on the redistribution of Fas to lipid rafts and the formation of the death-inducing signal complex (DISC).
- Investigating the regulatory mechanisms of the TNF-α/TNFR1 signaling pathway by S-nitrosylation.
Main Results:
- S-nitrosylation of death receptor DR4 promotes apoptosis upon treatment with an NO donor.
- S-nitrosylation of Fas, induced by glyceryl trinitrate (GTN), facilitates its redistribution to lipid rafts and DISC formation, leading to apoptosis.
- S-nitrosylation emerges as a critical post-translational modification controlling cell fate in TNF-family death receptor signaling.
Conclusions:
- S-nitrosylation is a key regulatory mechanism in TNF-family death receptor signaling pathways.
- Targeting S-nitrosylation of death receptors presents a promising therapeutic strategy to overcome apoptotic resistance in tumors.
- Further research into NO-mediated regulation of TNF-α/TNFR1 signaling could uncover novel anti-cancer treatments.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...